Murat Yildirim, MD, PhD, serves as a Senior Global Medical Advisor in the Medical Affairs, Medical Strategy and Communication Department of Psychiatry at Lundbeck since June 2010, focusing on aripiprazole formulations for schizophrenia and bipolar I disorder. Previous roles at Lundbeck include Global Medical Advisor and Principal Global Safety Physician, overseeing multiple psychiatric and neurological medications. Prior experience includes a Medical Manager position at Roche in oncology and post-doctoral research appointments at prestigious institutions such as Gülhane Military Medical Academy, Icahn School of Medicine at Mount Sinai, and Yale University School of Medicine. Education includes a PhD in Pharmacology and an MD in Medicine, both from Hacettepe University.